Biotech

All Articles

Pfizer takes $230M reached after axing failed DMD gene treatment

.Pfizer's stage 3 Duchenne muscle dystrophy (DMD) genetics therapy failure has blown a $230 thousand...

AC Immune views 'site' prospective in Alzheimer's medicine information

.After more than twenty years of work on neurodegenerative diseases, Swiss biotech air conditioning ...

GSK drops ph. 2 HPV vaccination over lack of best-in-class possible

.GSK has junked a stage 2 individual papillomavirus (HPV) vaccination from its own pipeline after de...

OS Therapies refiles $6M IPO to fund HER2 medication, preclinical ADCs

.Operating system Therapies will certainly detail on the NYSE American inventory substitution this m...

ALX's waning CD47 response fee delivers sell spiraling down

.ALX Oncology's period 2 gastric cancer feedback cost has actually damaged. After viewing its CD47 b...

Ionis centers eye ailment coming from targets of Roche-partnered possibility after data dissatisfy

.Another of Ionis Pharmaceuticals' vital midphase readouts has disappointed requirements, motivating...

Biogen's CEO claimed no dangerous deals in 2023. He's ready to become vibrant

.While Biogen's pharma peers are actually looking for late-stage properties with little bit of dange...

Instil refills pipeline in $2B biobucks handle ImmunOnco

.Instil Biography has been actually a biotech in search of a pipe after it scrapped its lead possess...

Biogen leaves Denali Alzheimer's collab

.Biogen has actually handed back civil rights to an early Alzheimer's condition system to Denali The...

Takeda touches new head of US oncology business-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our roundup of significant management hirings, firings a...